- Overcoming the Biggest Obstacle to Improving Alzheimer’s Treatments -
Vienna, July 12, 2009 – Partnering with local physicians, working with local clinics, and conducting educational seminars and health fairs were found to be the most effective tools in recruiting people for Alzheimer’s clinical studies, according to new research reported today at the Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease (ICAD 2009) in Vienna.
Surprisingly, patient registries and Internet recruiting were found to be much less successful recruitment strategies, according to staff at the U.S. Alzheimer’s Disease Centers (ADCs). The National Institute on Aging (NIA) funds 30 ADCs at major medical institutions across the nation.
“Second only to inadequate funding, recruiting participants for clinical studies is the single greatest barrier to developing better treatments for Alzheimer’s disease,” according to William Thies, PhD, Chief Medical & Scientific Officer at the Alzheimer’s Association. “These studies give us clear information – from people who are conducting large scale clinical trials now – on how we may recruit participants better and faster in the future.”
In another study looking specifically at recruiting African Americans for Alzheimer’s genetics studies, researchers found that having a relative with the disease, use of minority study personnel, and monetary compensation were the most powerful incentives for participation in research.
The studies reported at ICAD 2009 were:
– Tamara S. Markgraf, et al – Recruiting for Alzheimer’s disease Research: A systematic review of recruitment techniques and challenges among NIH funded ADRCs.
– Goldie S. Byrd, et al – Ascertaining Older African Americans for Genetic Studies in Alzheimer’s Disease.
– Ulrika Akenine, et al – Why AD patients and caregivers participate in randomized clinical trials.
For more information, visit: http://www.alz.org